| # | Title | Journal | Year | Citations |
|---|
| 1 | Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) | Autophagy | 2016 | 4,701 |
| 2 | von Hippel-Lindau disease | Lancet, The | 2003 | 1,322 |
| 3 | Comparison of MR/Ultrasound Fusion–Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer | JAMA - Journal of the American Medical Association | 2015 | 1,267 |
| 4 | Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome | Cancer Cell | 2002 | 833 |
| 5 | Mutations in the Fumarate Hydratase Gene Cause Hereditary Leiomyomatosis and Renal Cell Cancer in Families in North America | American Journal of Human Genetics | 2003 | 563 |
| 6 | Thalidomide | Lancet, The | 2004 | 535 |
| 7 | Novel mutations of the MET proto-oncogene in papillary renal carcinomas | Oncogene | 1999 | 487 |
| 8 | Multiparametric 3T Prostate Magnetic Resonance Imaging to Detect Cancer: Histopathological Correlation Using Prostatectomy Specimens Processed in Customized Magnetic Resonance Imaging Based Molds | Journal of Urology | 2011 | 440 |
| 9 | Magnetic Resonance Imaging/Ultrasound–Fusion Biopsy Significantly Upgrades Prostate Cancer Versus Systematic 12-core Transrectal Ultrasound Biopsy | European Urology | 2013 | 436 |
| 10 | Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma | Cell | 2019 | 430 |
| 11 | Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling | Proceedings of the National Academy of Sciences of the United States of America | 2006 | 427 |
| 12 | The contribution of VHL substrate binding and HIF1-α to the phenotype of VHL loss in renal cell carcinoma | Cancer Cell | 2002 | 421 |
| 13 | Heat shock protein 90 | Current Opinion in Oncology | 2003 | 365 |
| 14 | Germline BHD-Mutation Spectrum and Phenotype Analysis of a Large Cohort of Families with Birt-Hogg-Dubé Syndrome | American Journal of Human Genetics | 2005 | 363 |
| 15 | Birt-Hogg-Dubé Syndrome, a Genodermatosis Associated with Spontaneous Pneumothorax and Kidney Neoplasia, Maps to Chromosome 17p11.2 | American Journal of Human Genetics | 2001 | 355 |
| 16 | VON RECKLINGHAUSEN′S DISEASE AND PHEOCHROMOCYTOMAS | Journal of Urology | 1999 | 317 |
| 17 | Plasma methoxytyramine: A novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status | European Journal of Cancer | 2012 | 304 |
| 18 | PERCUTANEOUS RADIO FREQUENCY ABLATION OF SMALL RENAL TUMORS: INITIAL RESULTS | Journal of Urology | 2002 | 300 |
| 19 | Measurements of Plasma Methoxytyramine, Normetanephrine, and Metanephrine as Discriminators of Different Hereditary Forms of Pheochromocytoma | Clinical Chemistry | 2011 | 282 |
| 20 | Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment | Familial Cancer | 2014 | 251 |
| 21 | Hereditary Leiomyomatosis and Renal Cell Cancer: A Syndrome Associated With an Aggressive Form of Inherited Renal Cancer | Journal of Urology | 2007 | 235 |
| 22 | CLINICAL AND GENETIC CHARACTERIZATION OF PHEOCHROMOCYTOMA IN VON HIPPEL-LINDAU FAMILIES: COMPARISON WITH SPORADIC PHEOCHROMOCYTOMA GIVES INSIGHT INTO NATURAL HISTORY OF PHEOCHROMOCYTOMA | Journal of Urology | 1999 | 233 |
| 23 | Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine tumors (PNETs) | Surgery | 2007 | 232 |
| 24 | RENAL CANCER IN FAMILIES WITH HEREDITARY RENAL CANCER: PROSPECTIVE ANALYSIS OF A TUMOR SIZE THRESHOLD FOR RENAL PARENCHYMAL SPARING SURGERY | Journal of Urology | 1999 | 229 |
| 25 | Multiparametric Magnetic Resonance Imaging and Ultrasound Fusion Biopsy Detect Prostate Cancer in Patients with Prior Negative Transrectal Ultrasound Biopsies | Journal of Urology | 2012 | 227 |
| 26 | Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers | Nature Reviews Urology | 2014 | 227 |
| 27 | Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial | Lancet Infectious Diseases, The | 2015 | 216 |
| 28 | Succinate Dehydrogenase Kidney Cancer: An Aggressive Example of the Warburg Effect in Cancer | Journal of Urology | 2012 | 211 |
| 29 | Robotic Partial Nephrectomy for Complex Renal Tumors: Surgical Technique | European Urology | 2008 | 210 |
| 30 | Focal Therapy: Patients, Interventions, and Outcomes—A Report from a Consensus Meeting | European Urology | 2015 | 206 |
| 31 | Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer | Cancer | 2013 | 205 |
| 32 | Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2 | Proceedings of the National Academy of Sciences of the United States of America | 2009 | 203 |
| 33 | PARENCHYMAL SPARING SURGERY IN PATIENTS WITH HEREDITARY RENAL CELL CARCINOMA: 10-YEAR EXPERIENCE | Journal of Urology | 2001 | 198 |
| 34 | Targeting the HGF/Met signaling pathway in cancer therapy | Expert Opinion on Therapeutic Targets | 2012 | 197 |
| 35 | Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations—A Report of a European School of Oncology Task Force | European Urology | 2017 | 190 |
| 36 | Hepatocyte growth factor/MET in cancer progression and biomarker discovery | Cancer Science | 2017 | 190 |
| 37 | Serum Vascular Endothelial Growth Factor-D Prospectively Distinguishes Lymphangioleiomyomatosis From Other Diseases | Chest | 2010 | 188 |
| 38 | THE RELATIONSHIP BETWEEN RENAL TUMOR SIZE AND METASTASES IN PATIENTS WITH VON HIPPEL-LINDAU DISEASE | Journal of Urology | 2004 | 181 |
| 39 | Targeting the HGF/Met signalling pathway in cancer | European Journal of Cancer | 2010 | 180 |
| 40 | Sarcomatoid Renal Cell Carcinoma: A Comprehensive Review of the Biology and Current Treatment Strategies | Oncologist | 2012 | 177 |
| 41 | Molecular genetics and clinical features of Birt–Hogg–Dubé syndrome | Nature Reviews Urology | 2015 | 175 |
| 42 | Molecular Pathways: Fumarate Hydratase-Deficient Kidney Cancer—Targeting the Warburg Effect in Cancer | Clinical Cancer Research | 2013 | 172 |
| 43 | Utility of Multiparametric Magnetic Resonance Imaging Suspicion Levels for Detecting Prostate Cancer | Journal of Urology | 2013 | 171 |
| 44 | Von Hippel-Lindau (VHL) Inactivation in Sporadic Clear Cell Renal Cancer: Associations with Germline VHL Polymorphisms and Etiologic Risk Factors | PLoS Genetics | 2011 | 168 |
| 45 | Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia | Leukemia | 2007 | 167 |
| 46 | Identification and characterization of a novel folliculin-interacting protein FNIP2 | Gene | 2008 | 163 |
| 47 | The Metabolic Basis of Kidney Cancer | Cancer Discovery | 2019 | 163 |
| 48 | HISTOPATHOLOGY AND MOLECULAR GENETICS OF RENAL TUMORS: TOWARD UNIFICATION OF A CLASSIFICATION SYSTEM | Journal of Urology | 1999 | 155 |
| 49 | Laparoscopic cytoreductive nephrectomy as preparation for administration of systemic interleukin-2 in the treatment of metastatic renal cell carcinoma: a pilot study | Urology | 1999 | 154 |
| 50 | Robotic Partial Nephrectomy for Renal Hilar Tumors: A Multi-Institutional Analysis | Journal of Urology | 2008 | 147 |
